|
|
|
|
|
|
|
|
|
14.08.25 - 22:30
|
Apple Watch Blood Oxygen Tracker Back in US (Bloomberg)
|
|
|
Apple Inc. is restoring the blood oxygen tracking feature on its smartwatch in the US following a years-long legal fight. The feature — which was removed at the end of 2023 due to a patent infringement lawsuit filed by Masimo Corp. and a US Customs injunction — will return for Apple Watch owners who bought models with the feature disabled, the company said Thursday, citing a ruling by US Customs. The restoration comes as part of iOS 18.6.1 and watchOS 11.6.1 software updates — and includes a workaround that shows the data on an iPhone rather than the Apple Watch blood oxygen app itself. The development is hitting at a key time for Apple. The company is expected to unveil new Apple Watch models next month, alongside its iPhone 17 line. Now it will once again be able to market that health feature alongside other tools like heart rate monitoring. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.08.25 - 00:18
|
Masimo Corporation Announces Advance In Q2 Profit (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Masimo Corporation (MASI) reported a profit for its second quarter that Increases, from last yearThe company's bottom line came in at $44.9 million, or $0.82 per share. This......
|
|
|
|
|
05.08.25 - 22:09
|
Masimo Reports Second Quarter 2025 Results (Business Wire)
|
|
|
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 28, 2025.
Second Quarter 2025 Results From Continuing Operations(1):
GAAP revenue of $371 million, representing 8% growth on a reported basis;
Non-GAAP revenue of $370 million, representing 7% growth on a constant currency basis(2);
GAAP net income per diluted share of $0.82; and
Non-GAAP net income per diluted share(2) of $1.33, which grew 46% versus prior year period.
Katie Szyman, Chief Executive Officer of Masimo, said, “We once again delivered strong results in the second quarter as our core health care business continued to demonstrate strong growth and earnings. We are intensely focused on building our leading position in pulse oximetry to increase our market share in key global markets and advanced monitoring categories, and on driving commercial excellence throughout the organization. We have also expanded our leadership team to ensure that we have the right...
|
|
|
|
|
22.07.25 - 15:03
|
Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5 (Business Wire)
|
|
|
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday, August 5, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and Micah Young, Chief Financial Officer.
To register for the conference call and receive the dial-in number, please use the link below. Upon registering, each participant will be provided with details including the dial-in number and a registrant ID number. Reminders about the call will also be sent to registered participants via email.
Conference Call Registration Link (Please register to obtain the dial-in number):
https://registrations.events/direct/Q4I4072834
A replay of the webcast and conference call will be available shortly after the conclusion of the call and will be archived on the Company's web...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
